Position Summary
The (Sr.) Director of Value, Access and Policy, Europe, plays a crucial role as a key partner on Acadia’s Global Value & Access Team, as well as the European Value, Access and Policy team. This position is accountable for achieving and maintaining optimal pricing and market access through propositions that deliver value to patients, healthcare systems, society, and the company. Alongside the Head of the European Value, Access and Policy team, the (Sr.) Director will shape Acadia’s Market Access strategy in Europe and build an organization that can execute this strategy effectively across functions. Additionally, this role will define product access strategies and ensure that local needs, such as additional evidence, are identified and communicated effectively.
Primary Responsibilities
- Support mid-sized and small European countries as a primary focus.
- Ensure high-quality pricing and access launch strategies tailored for the focus countries.
- Develop pricing and access strategies based on insights, incorporating additional evidence needs, value propositions beyond the drug, managed entry schemes, and other agreements to ensure mutual value.
- Ensure timely delivery of high-quality P&R dossiers.
- Collaborate with local and European teams to identify evidence requirements essential for successful access in Europe, supporting the creation of program-specific Evidence Plans.
- Establish a coordinated negotiation strategy with a clearly defined approach.
- Build and maintain relationships with a wide array of stakeholders to support access engagement and education, including consultations with patients regarding their needs and the impact of the disease within their local context.
- Prepare and manage annual strategic plans and budgets for the function with accurate forecasts and prudent decision-making.
- Monitor trends and anticipate key developments in Europe pertaining to Health Technology Assessment and Government/Payer reimbursement initiatives.
Education/Experience/Skills
A Bachelor’s degree is required; an MBA or PhD in science and/or economics is preferred. A minimum of 10 years of progressively responsible experience in Market Access within a pharmaceutical or biotech organization, with significant scientific exposure to rare diseases, ideally in the CNS realm and in the context of early patient access programs, is essential. A combination of relevant education and applicable experience may also be considered.
Key Skills
- Recent experience in early patient access programs and the launch of orphan drugs, ideally with direct or adjacent experience in the CNS space.
- Hands-on experience in pricing negotiations across one or more European markets.
- Demonstrated success in cross-functional teamwork.
- Fluency in English (both written and oral) is mandatory; proficiency in additional European languages is a plus.
- Ability to collaborate cross-functionally with colleagues from commercial, medical, clinical, and regulatory backgrounds to foster a culture of collaboration and innovation.
- Strong digital literacy and proficiency in Microsoft applications, particularly Excel and PowerPoint.
- Excellent written and oral communication skills, including strong formal presentation abilities.
- Willingness to travel, both within Europe and internationally.
Apply online using the form below. Please note that only applications matching the job profile will be considered.